FIELD: biochemistry.
SUBSTANCE: invention relates to biochemistry. Conditionally deficient cytomegalovirus (CMV) replication for CMV prophylaxis with destabilized IE1/2 and UL51 proteins is proposed, and also a method for its preparation, use and composition.
EFFECT: invention can be used to prevent CMV infection.
15 cl, 16 dwg, 7 ex, 2 tbl
Title | Year | Author | Number |
---|---|---|---|
CONDITIONALLY REPLICATING CYTOMEGALOVIRUS AS VACCINE AGAINST CMV | 2012 |
|
RU2611198C2 |
STABLE COMPOSITIONS OF CYTOMEGALOVIRUS | 2018 |
|
RU2800361C2 |
ANTIGEN DELIVERY PLATFORMS | 2011 |
|
RU2597974C2 |
CYTOMEGALOVIRUS VACCINE AND METHOD FOR PREPARING IT | 2008 |
|
RU2491340C2 |
METHODS FOR DETECTION OF ANTI-CYTOMEGALOVIRUS NEUTRALIZING ANTIBODIES | 2013 |
|
RU2660712C2 |
COMPOSITIONS AND METHODS FOR TREATING CYTOMEGALOVIRUS | 2012 |
|
RU2737530C1 |
COMPOSITION CONTAINING HCMV PARTICLES | 2008 |
|
RU2505314C2 |
CATIONIC OIL-IN-WATER EMULSIONS | 2012 |
|
RU2649133C2 |
MUTANT HERPES VIRUS-COMPRISING VACCINE | 1991 |
|
RU2236256C2 |
PEGYLATED LIPOSOMES FOR IMMUNOUGEN-CODING RNA DELIVERY | 2012 |
|
RU2628705C2 |
Authors
Dates
2018-10-17—Published
2012-09-04—Filed